Navigation Links
Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website
Date:8/8/2009

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Herbal Fen Phen Lawyers (http://www.herbalfenphenlawyers.com/). Herbal Fen Phen products have been marketed to former patients as a “natural alternative” to Fen Phen, despite warnings from the FDA that herbal Fen Phen may be linked to serious side effects, including primary pulmonary hypertension (PPH), high blood pressure, heart attacks, strokes or death.

(Vocus) August 8, 2009 -- The law firm of Hissey Kientz, LLP is pleased to announce the launch of its new website, Herbal Fen Phen Lawyers (http://www.herbalfenphenlawyers.com/). The site will serve as a news and information resource for individuals who may have suffered injuries such as primary pulmonary hypertension after using products marketed as “herbal Fen Phen” or other dietary supplements containing ephedra.

After Pondimin (fenfluramine) and Redux (dexfenfluramine)—two drugs that were prescribed as part of the diet drug combination Fen Phen—were recalled in September 1997, some companies began marketing over-the-counter supplements touted as an “all natural” and “herbal” equivalent. These herbal Fen Phen supplements usually contained a combination of two ingredients: ephedra (ma huang) and St. John’s wort.

In November 1997—just two months after the Fen Phen recall was issued—the Food and Drug Administration issued a warning about herbal Fen Phen products that were being marketed to former patients as a “natural alternative” to Fen Phen. The agency warned that herbal Fen Phen may contain ingredients that had been linked to serious side effects, including high blood pressure, heart attacks, strokes and death.

In addition, herbal Fen Phen has also been associated with a condition known as primary pulmonary hypertension (PPH). Patients with PPH experience high blood pressure in the artery that carries blood from the heart to the lungs. Without proper treatment, PPH can cause the heart to have to work harder to pump blood, potentially leading to heart failure or death.

The early symptoms of PPH can mimic those of other conditions, which can lead to delays in properly diagnosing the disease. The most commonly reported symptoms of PPH include shortness of breath, weakness and repeated fainting or passing out. Women are more likely to show early PPH symptoms than men.

A physician may wish to perform medical tests in order to rule out other diseases and confirm a PPH diagnosis. These can include simple blood tests; a physical examination to check for irregular heart sounds; heart catheterization; a CT scan, chest X-ray, echocardiogram or other imaging studies.

Once a PPH diagnosis has been confirmed, a doctor may prescribe a number of possible treatments. These can include prescription medications such as Letairis, warfarin, Digitek (digoxin), Flonan, Remodulin or Tracleer; as well as changes in a patient’s diet or mild exercise. A lung or heart transplant may be necessary depending on how soon a diagnosis is made, the severity of symptoms and how a patient responds to treatment.

About Hissey Kientz, LLP
Hissey Kientz, LLP (Fleet Phospho Soda; digoxin toxicity from Digitek; the Composix Kugel mesh hernia patch; renal failure caused by Trasylol; the Duragesic or fentanyl pain patch; Raptiva; FELA railroad injuries; gadolinium MRI contrast dyes or other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP or call toll-free at (866) 275-4454.

###

Read the full story at http://www.prweb.com/releases/herbal-fen-phen/ephedra/prweb2728914.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
2. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
3. Hissey Kientz, LLP Warns Duragesic Patch Users About Potential Health Risks of Fentanyl Overdose
4. Hissey Kientz, LLP Announces the Launch of Mesothelioma Lawyers Help Web Site
5. Supreme Court Ruling is a Victory for Consumers Injured by Dangerous Drugs, Says Hissey Kientz, LLP
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website
(Date:8/16/2017)... ... August 16, 2017 , ... The next Patient Care Academy ... , Students who successfully complete the seven-week long Patient Care Academy are eligible ... The average starting salary for a CNA in Kalamazoo is $24,428.* , As a ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Greenfield Advisors is ... in the U.S. for the second year in a row. The Inc. 5000 list ... three years. , “To be on the list once is a great accomplishment, but ...
(Date:8/16/2017)... ... August 16, 2017 , ... Any Lab Test Now® is thrilled ... on the newly released, 36th annual Inc. 5000 , the most prestigious compilation ... most successful companies within the American economy’s most dynamic segment — its independent small ...
(Date:8/16/2017)... ... 2017 , ... In a recent survey, eighty-two percent of women reported having ... cellulite can't always be eliminated by diet and exercise alone, and now for the ... nationwide. Dr. Kenneth Rothaus has recently added Cellulaze™ to his practice in ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Maury Regional Health ... and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical Center is making ... the guesswork out of a needle stick and more importantly, helps our staff members ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics , ... Dallas, Texas , has received notice from the ... Institutes of Health (NIH) that it has been awarded ... totaling over $650,000 in 2017 with an additional $1,000,000 ... Investigational New Drug application of their lead non-opioid drug ...
(Date:7/28/2017)... , July 28, 2017 EnvoyHealth, a Diplomat ... pilot a program for CleverCap LITE, a technology designed ... strives to deliver innovative health technology solutions and services ... CleverCap LITE offers medication ... high-tech bottle cover: ...
(Date:7/26/2017)... Fla. , July 26, 2017 Sancilio ... enrollment of our clinical trial evaluating Altemia TM , ... Anemia (SCA) and Sickle Cell Disease (SCD). The SCOT ... evaluate the efficacy and safety of Altemia TM ... is conducted under US IND 125274. ...
Breaking Medicine Technology: